A detailed history of Mc Lean Asset Management Corp transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Mc Lean Asset Management Corp holds 6,349 shares of BMY stock, worth $341,322. This represents 0.08% of its overall portfolio holdings.

Number of Shares
6,349
Previous 7,224 12.11%
Holding current value
$341,322
Previous $373 Million 29.96%
% of portfolio
0.08%
Previous 0.13%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 11, 2024

SELL
$40.25 - $52.99 $35,218 - $46,366
-875 Reduced 12.11%
6,349 $261 Million
Q1 2024

Apr 10, 2024

SELL
$47.98 - $54.4 $9,835 - $11,152
-205 Reduced 2.76%
7,224 $373 Million
Q4 2023

Jan 08, 2024

SELL
$48.48 - $57.85 $3,054 - $3,644
-63 Reduced 0.84%
7,429 $388 Million
Q3 2023

Oct 11, 2023

SELL
$57.89 - $64.73 $3,531 - $3,948
-61 Reduced 0.81%
7,492 $422 Million
Q2 2023

Jul 10, 2023

BUY
$63.71 - $70.74 $3,822 - $4,244
60 Added 0.8%
7,553 $483 Million
Q1 2023

Apr 11, 2023

SELL
$65.71 - $74.53 $14,653 - $16,620
-223 Reduced 2.89%
7,493 $519 Million
Q4 2022

Jan 19, 2023

BUY
$68.48 - $81.09 $2,191 - $2,594
32 Added 0.42%
7,716 $555 Million
Q3 2022

Oct 12, 2022

SELL
$0.13 - $76.84 $7 - $4,303
-56 Reduced 0.72%
7,684 $536,000
Q2 2022

Jul 07, 2022

SELL
$72.62 - $79.98 $2,469 - $2,719
-34 Reduced 0.44%
7,740 $590,000
Q1 2022

Apr 08, 2022

BUY
$61.48 - $73.72 $7,439 - $8,920
121 Added 1.58%
7,774 $568,000
Q4 2021

Jan 14, 2022

BUY
$53.63 - $62.52 $18,448 - $21,506
344 Added 4.71%
7,653 $496,000
Q3 2021

Oct 27, 2021

BUY
$59.17 - $69.31 $61,181 - $71,666
1,034 Added 16.48%
7,309 $426,000
Q2 2021

Jul 19, 2021

BUY
$61.91 - $67.42 $3,900 - $4,247
63 Added 1.01%
6,275 $422,000
Q1 2021

Apr 28, 2021

SELL
$59.34 - $66.74 $11,333 - $12,747
-191 Reduced 2.98%
6,212 $410,000
Q4 2020

Jan 27, 2021

BUY
$57.74 - $65.43 $369,709 - $418,948
6,403 New
6,403 $397,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $114B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Mc Lean Asset Management Corp Portfolio

Follow Mc Lean Asset Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mc Lean Asset Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Mc Lean Asset Management Corp with notifications on news.